Sign in
SCHEDULE 13G/A

Statement of Beneficial Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0000935836-26-000588

Stakes reported in this filing

Reporting person Shares Of the class
EcoR1 Capital, LLC 6,803,785 8.9%
Oleg Nodelman 6,803,785 8.9%
EcoR1 Capital Fund Qualified, L.P. 6,297,538 8.2%

Members of a group can each report the same shares, so these rows overlap and don't add up.

Loading xslSCHEDULE_13G_X02/primary_doc.xml…